Spanish Breast Cancer Research Group
- Country
- 🇪🇸Spain
- Ownership
- Private
- Established
- 1995-01-01
- Employees
- 101
- Market Cap
- -
- Website
- https://www.geicam.org
Capecitabine Plus Radiotherapy for Local Relapse Breast Cancer With Negative Her2 Tumours
- First Posted Date
- 2007-02-14
- Last Posted Date
- 2019-02-21
- Lead Sponsor
- Spanish Breast Cancer Research Group
- Target Recruit Count
- 1
- Registration Number
- NCT00434941
- Locations
- 🇪🇸
Hospital Infanta Cristina, Badajoz, Spain
🇪🇸Hospital Universitario de la Princesa, Madrid, Spain
🇪🇸Hospital Clínico Universitario San Carlos, Madrid, Spain
Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2007-02-07
- Last Posted Date
- 2023-04-03
- Lead Sponsor
- Spanish Breast Cancer Research Group
- Target Recruit Count
- 189
- Registration Number
- NCT00432172
- Locations
- 🇪🇸
Onkologikoa, Donostia, Gipuzkoa, Spain
🇪🇸Hospital Mutua de Terrassa, Terrassa, Barcelona, Spain
🇪🇸Centro Oncológico Regional de Galicia, A Coruña, Spain
Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2005-11-28
- Last Posted Date
- 2023-04-04
- Lead Sponsor
- Spanish Breast Cancer Research Group
- Target Recruit Count
- 49
- Registration Number
- NCT00258960
- Locations
- 🇪🇸
Hospital Puerta del Mar, Cadiz, Spain
🇪🇸Hospital Clinic i Provincial, Barcelona, Spain
🇪🇸Hospital Juan Canalejo, La Coruña, Spain
Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions
- First Posted Date
- 2005-08-15
- Last Posted Date
- 2019-04-16
- Lead Sponsor
- Spanish Breast Cancer Research Group
- Target Recruit Count
- 97
- Registration Number
- NCT00130494
- Locations
- 🇪🇸
Spanish Breast Cancer Research Group (GEICAM), San Sebastián de los Reyes, Madrid, Spain
Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With Trastuzumab
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2005-08-15
- Last Posted Date
- 2019-02-26
- Lead Sponsor
- Spanish Breast Cancer Research Group
- Target Recruit Count
- 14
- Registration Number
- NCT00130507
- Locations
- 🇪🇸
Spanish Breast Cancer Research Group (GEICAM), San Sebastián de los Reyes, Madrid, Spain
Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients
- First Posted Date
- 2005-08-15
- Last Posted Date
- 2023-03-31
- Lead Sponsor
- Spanish Breast Cancer Research Group
- Target Recruit Count
- 876
- Registration Number
- NCT00130533
- Locations
- 🇪🇸
Hospital General Universitario Morales Meseguer, Murcia, Spain
🇪🇸Hospital Regional Universitario Carlos Haya, Málaga, Spain
🇪🇸Hospital Universitario Virgen del Rocío, Sevilla, Spain
Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2005-08-12
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- Spanish Breast Cancer Research Group
- Target Recruit Count
- 1289
- Registration Number
- NCT00129922
- Locations
- 🇪🇸
Hospital del Mar, Barcelona, Spain
🇪🇸Hospital General Universitario de Elche, Elche, Alicante, Spain
🇪🇸Hospital Universitario Puerto Real, Puerto Real, Cádiz, Spain
EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2005-08-12
- Last Posted Date
- 2023-03-31
- Lead Sponsor
- Spanish Breast Cancer Research Group
- Target Recruit Count
- 1384
- Registration Number
- NCT00129935
- Locations
- 🇪🇸
Hospital Arquitecto Marcide, Ferrol, A Coruña, Spain
🇪🇸Hospital General Universitario de Elche, Elche, Alicante, Spain
🇪🇸Hospital General Universitario de Elda, Elda, Alicante, Spain
Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients
- First Posted Date
- 2005-08-12
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- Spanish Breast Cancer Research Group
- Target Recruit Count
- 73
- Registration Number
- NCT00129896
- Locations
- 🇪🇸
Hospital Universitario Virgen de los Lirios, Alcoy, Alicante, Spain
🇪🇸Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain
🇪🇸Consorci Sanitari de Terrassa, Terrassa, Barcelona, Spain
FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2005-08-11
- Last Posted Date
- 2023-03-07
- Lead Sponsor
- Spanish Breast Cancer Research Group
- Target Recruit Count
- 1925
- Registration Number
- NCT00129389
- Locations
- 🇪🇸
Hospital General de Elda, Elda, Alicante, Spain
🇪🇸Consorci Sanitari Terrassa, Terrassa, Barcelona, Spain
🇪🇸Hospital Clínico Universitario de Salamanca, Salamanca, Spain